Carbidopa and Levodopa
NDC 51079-923, carbidopa and levodopa, tablet, extended release, from Mylan Institutional Inc..
- Product NDC
- 51079-923
- Status
- Listed
- Labeler
- Mylan Institutional Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075091
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51079-923 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBIDOPA50 mg/1
- LEVODOPA200 mg/1
Pharmacologic classes
Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51079-923-20 | 51079092320 | 100 BLISTER PACK in 1 CARTON (51079-923-20) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51079-923-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/16f9e4d1-6953-4d4f-b4cf-ad95a856ac25NADAC price for package 51079092320
GET /v1/drugs/nadac/51079092320
Use it
Look up 51079-923 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51079-923 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51079-923. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.